Study
Probiotic Supplement Shows Potential in Easing Mild Respiratory Symptoms
A new study suggests that Lactobacillus plantarum may help reduce mild respiratory symptoms in adults who don't have asthma or COPD.
Summary
In plain language
Recent research explored how a specific probiotic, Lactobacillus plantarum, might aid adults with mild respiratory symptoms like coughing and breathlessness. The study involved 90 participants aged 19 to 70 who took either the probiotic or a placebo daily for 12 weeks. While overall improvements in symptoms were noted, differences between the probiotic and placebo groups were not statistically significant. However, some benefits were observed, particularly in men and those over 40. This research is important for seniors as it highlights potential new options for managing respiratory discomfort, especially for those who don't find relief from standard treatments. Discussing these findings with a healthcare provider can help decide if probiotics might be beneficial.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a double-blind, randomized trial involving 90 participants without asthma or COPD, who experienced mild respiratory symptoms. They were divided into two groups, one receiving the probiotic Lactobacillus plantarum and the other a placebo, for 12 weeks.
The study found some numerical improvements in symptoms like breathlessness and sputum, although these were not statistically significant compared to the placebo.
Subgroup analysis suggested that men and individuals over 40 might see more benefits from the probiotic.
Limitations include the possibility of bias due to a 27.6% dropout rate, which could affect results.
Seniors should consider discussing this with their healthcare providers to see if probiotics might be a useful addition to their health routine.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Probiotic Supplement Shows Potential in Easing Mild Respiratory Symptoms
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in design and bias control due to its rigorous RCT methodology. Statistical integrity was slightly lower due to exploratory analyses without multiple comparison adjustments. Transparency was high with pre-registration and adherence to CONSORT. Conflicts of interest were significant due to author affiliations with the product manufacturer. Relevance was partial due to the inclusion of a wide age range but with subgroup analysis for older adults. Journal quality could not be assessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 7.5/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This study investigated the effects of the probiotic GCWB1001 on mild respiratory symptoms in a double-blind, randomized, placebo-controlled trial. While no significant improvement was found in the primary outcome, exploratory analyses suggested potential benefits in certain subgroups.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes it difficult to breathe. It primarily affects the airways and air sacs in the lungs, leading to airflow limitations and breathing difficulties.
Asthma
Asthma is a chronic respiratory condition that affects the airways of the lungs. It causes inflammation and narrowing of the airways, leading to breathing difficulties. While asthma can affect people of all ages, it can be particularly challenging for seniors.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.